These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1160 related articles for article (PubMed ID: 33766124)

  • 21. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection.
    Li M; Ayyanathan K; Dittmar M; Miller J; Tapescu I; Lee JS; McGrath ME; Xue Y; Vashee S; Schultz DC; Frieman MB; Cherry S
    mBio; 2023 Aug; 14(4):e0119423. PubMed ID: 37377442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative comparison of nuclear transport inhibition by SARS coronavirus ORF6 reveals the importance of oligomerization.
    Yoo TY; Mitchison TJ
    Proc Natl Acad Sci U S A; 2024 Jan; 121(4):e2307997121. PubMed ID: 38236733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics.
    Schroeder S; Pott F; Niemeyer D; Veith T; Richter A; Muth D; Goffinet C; Müller MA; Drosten C
    Lancet Microbe; 2021 May; 2(5):e210-e218. PubMed ID: 33969329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe Acute Respiratory Syndrome Coronavirus ORF7a Inhibits Bone Marrow Stromal Antigen 2 Virion Tethering through a Novel Mechanism of Glycosylation Interference.
    Taylor JK; Coleman CM; Postel S; Sisk JM; Bernbaum JG; Venkataraman T; Sundberg EJ; Frieman MB
    J Virol; 2015 Dec; 89(23):11820-33. PubMed ID: 26378163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.
    Miorin L; Kehrer T; Sanchez-Aparicio MT; Zhang K; Cohen P; Patel RS; Cupic A; Makio T; Mei M; Moreno E; Danziger O; White KM; Rathnasinghe R; Uccellini M; Gao S; Aydillo T; Mena I; Yin X; Martin-Sancho L; Krogan NJ; Chanda SK; Schotsaert M; Wozniak RW; Ren Y; Rosenberg BR; Fontoura BMA; García-Sastre A
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28344-28354. PubMed ID: 33097660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.
    Hassan SS; Choudhury PP; Dayhoff GW; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Pizzol D; Adadi P; Lal A; Soares A; Mohamed Abd El-Aziz T; Brufsky AM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Ã; Chauhan G; Palu G; Mishra YK; Barh D; Santana Silva RJ; Andrade BS; Azevedo V; Góes-Neto A; Bazan NG; Redwan EM; Tambuwala M; Uversky VN
    Arch Biochem Biophys; 2022 Mar; 717():109124. PubMed ID: 35085577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 ORF6 disrupts nucleocytoplasmic trafficking to advance viral replication.
    Miyamoto Y; Itoh Y; Suzuki T; Tanaka T; Sakai Y; Koido M; Hata C; Wang CX; Otani M; Moriishi K; Tachibana T; Kamatani Y; Yoneda Y; Okamoto T; Oka M
    Commun Biol; 2022 May; 5(1):483. PubMed ID: 35590097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists.
    Yuen CK; Lam JY; Wong WM; Mak LF; Wang X; Chu H; Cai JP; Jin DY; To KK; Chan JF; Yuen KY; Kok KH
    Emerg Microbes Infect; 2020 Dec; 9(1):1418-1428. PubMed ID: 32529952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational analysis of SARS-CoV-2 ORF6-KPNA2 binding interface and identification of potent small molecule inhibitors to recuse the host immune system.
    Suleman M; Said A; Khan H; Rehman SU; Alshammari A; Crovella S; Yassine HM
    Front Immunol; 2023; 14():1266776. PubMed ID: 38283360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.
    Meyers JM; Ramanathan M; Shanderson RL; Beck A; Donohue L; Ferguson I; Guo MG; Rao DS; Miao W; Reynolds D; Yang X; Zhao Y; Yang YY; Blish C; Wang Y; Khavari PA
    PLoS Pathog; 2021 Oct; 17(10):e1009412. PubMed ID: 34597346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ORF6, ORF8 and nucleocapsid proteins of SARS-CoV-2 inhibit type I interferon signaling pathway.
    Li JY; Liao CH; Wang Q; Tan YJ; Luo R; Qiu Y; Ge XY
    Virus Res; 2020 Sep; 286():198074. PubMed ID: 32589897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Manipulation of innate immune signaling pathways by SARS-CoV-2 non-structural proteins.
    Lu Y; Michel HA; Wang PH; Smith GL
    Front Microbiol; 2022; 13():1027015. PubMed ID: 36478862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets.
    Zhang J; Li Q; Cruz Cosme RS; Gerzanich V; Tang Q; Simard JM; Zhao RY
    mBio; 2021 Feb; 13(1):e0016922. PubMed ID: 35164548
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarbecovirus ORF6 proteins hamper induction of interferon signaling.
    Kimura I; Konno Y; Uriu K; Hopfensperger K; Sauter D; Nakagawa S; Sato K
    Cell Rep; 2021 Mar; 34(13):108916. PubMed ID: 33765414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SARS-CoV-2 ORF7a blocked autophagy flux by intervening in the fusion between autophagosome and lysosome to promote viral infection and pathogenesis.
    Li S; Li X; Liang H; Yu K; Zhai J; Xue M; Luo Z; Zheng C; Zhang H
    J Med Virol; 2023 Nov; 95(11):e29200. PubMed ID: 37916857
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoscopic Elucidation of Spontaneous Self-Assembly of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Open Reading Frame 6 (ORF6) Protein.
    Nishide G; Lim K; Tamura M; Kobayashi A; Zhao Q; Hazawa M; Ando T; Nishida N; Wong RW
    J Phys Chem Lett; 2023 Sep; 14(38):8385-8396. PubMed ID: 37707320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane.
    Frieman M; Yount B; Heise M; Kopecky-Bromberg SA; Palese P; Baric RS
    J Virol; 2007 Sep; 81(18):9812-24. PubMed ID: 17596301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of SARS-CoV-2 accessory proteins in immune evasion.
    Zandi M; Shafaati M; Kalantar-Neyestanaki D; Pourghadamyari H; Fani M; Soltani S; Kaleji H; Abbasi S
    Biomed Pharmacother; 2022 Dec; 156():113889. PubMed ID: 36265309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission.
    Ye C; Park JG; Chiem K; Dravid P; Allué-Guardia A; Garcia-Vilanova A; Pino Tamayo P; Shivanna V; Kapoor A; Walter MR; Kobie JJ; Plemper RK; Torrelles JB; Martinez-Sobrido L
    Microbiol Spectr; 2023 Jun; 11(3):e0065323. PubMed ID: 37191507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed MEA
    Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.